65 related articles for article (PubMed ID: 21805036)
1. The role of neuregulin4 and HER4 in gastrointestinal malignant lymphoma.
Ebi M; Kataoka H; Shimura T; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Tsukamoto H; Ozeki K; Tanida S; Kamiya T; Inagaki H; Joh T
Mol Med Rep; 2011; 4(6):1151-5. PubMed ID: 21805036
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
3. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
Riese DJ; Bermingham Y; van Raaij TM; Buckley S; Plowman GD; Stern DF
Oncogene; 1996 Jan; 12(2):345-53. PubMed ID: 8570211
[TBL] [Abstract][Full Text] [Related]
4. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of EGFR family-mediated HRG signals in human ovarian cancer.
Campiglio M; Ali S; Knyazev PG; Ullrich A
J Cell Biochem; 1999 Jun; 73(4):522-32. PubMed ID: 10733345
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.
Harari D; Tzahar E; Romano J; Shelly M; Pierce JH; Andrews GC; Yarden Y
Oncogene; 1999 Apr; 18(17):2681-9. PubMed ID: 10348342
[TBL] [Abstract][Full Text] [Related]
7. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer.
Hayes NV; Blackburn E; Smart LV; Boyle MM; Russell GA; Frost TM; Morgan BJ; Baines AJ; Gullick WJ
Clin Cancer Res; 2007 Jun; 13(11):3147-55. PubMed ID: 17545517
[TBL] [Abstract][Full Text] [Related]
9. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
Plowman GD; Green JM; Culouscou JM; Carlton GW; Rothwell VM; Buckley S
Nature; 1993 Dec; 366(6454):473-5. PubMed ID: 7902537
[TBL] [Abstract][Full Text] [Related]
10. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
[TBL] [Abstract][Full Text] [Related]
11. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation.
De Potter IY; Poumay Y; Squillace KA; Pittelkow MR
Exp Cell Res; 2001 Dec; 271(2):315-28. PubMed ID: 11716544
[TBL] [Abstract][Full Text] [Related]
12. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
Takai N; Jain A; Kawamata N; Popoviciu LM; Said JW; Whittaker S; Miyakawa I; Agus DB; Koeffler HP
Cancer; 2005 Dec; 104(12):2701-8. PubMed ID: 16265675
[TBL] [Abstract][Full Text] [Related]
13. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT.
Tzankov A; Hittmair A; Müller-Hermelink HK; Rüdiger T; Dirnhofer S
Virchows Arch; 2002 Dec; 441(6):614-7. PubMed ID: 12461620
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.
Carraway KL; Weber JL; Unger MJ; Ledesma J; Yu N; Gassmann M; Lai C
Nature; 1997 May; 387(6632):512-6. PubMed ID: 9168115
[TBL] [Abstract][Full Text] [Related]
15. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
16. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract][Full Text] [Related]
17. Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.
Nielsen TO; Friis-Hansen L; Poulsen SS; Federspiel B; Sorensen BS
PLoS One; 2014; 9(4):e94606. PubMed ID: 24728052
[TBL] [Abstract][Full Text] [Related]
18. Roles for neuregulins in human cancer.
Stove C; Bracke M
Clin Exp Metastasis; 2004; 21(8):665-84. PubMed ID: 16035612
[TBL] [Abstract][Full Text] [Related]
19. The neuregulin system of ligands and their receptors in rat islets of langerhans.
South JC; Blackburn E; Brown IR; Gullick WJ
Endocrinology; 2013 Jul; 154(7):2385-92. PubMed ID: 23610133
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma--combined performance of multiple markers.
van den Brand M; Mathijssen JJ; Garcia-Garcia M; Hebeda KM; Groenen PJ; Falini B; Serrano S; van Krieken JH
Haematologica; 2015 Sep; 100(9):e358-60. PubMed ID: 26069292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
